Clinical significance of TP53 (R72P) and MDM2 (T309G) polymorphisms in breast cancer patients.
Yadav P, Masroor M, Tanwer K, Mir R, Javid J, Ahmad I, Zuberi M, Kaza RC, Jain SK, Khurana N, Ray PC, Saxena A.
Yadav P, et al. Among authors: mir r.
Clin Transl Oncol. 2016 Jul;18(7):728-34. doi: 10.1007/s12094-015-1425-5. Epub 2015 Nov 9.
Clin Transl Oncol. 2016.
PMID: 26553387